NorthCrest Asset Manangement LLC Acquires 1,570 Shares of CME Group Inc. (NASDAQ:CME)

NorthCrest Asset Manangement LLC boosted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 14.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 12,717 shares of the financial services provider's stock after purchasing an additional 1,570 shares during the quarter. NorthCrest Asset Manangement LLC's holdings in CME Group were worth $3,374,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of CME. New Age Alpha Advisors LLC increased its holdings in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares during the period. Knuff & Co LLC acquired a new position in CME Group in the 4th quarter valued at $33,000. Banque Transatlantique SA acquired a new position in CME Group in the 4th quarter valued at $35,000. Whipplewood Advisors LLC acquired a new position in CME Group in the 4th quarter valued at $37,000. Finally, United Community Bank acquired a new position in CME Group in the 4th quarter valued at $37,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at CME Group

In other CME Group news, Director Charles P. Carey sold 500 shares of the company's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director now directly owns 4,900 shares of the company's stock, valued at $1,300,215. This represents a 9.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Dennis Suskind sold 1,000 shares of the company's stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the transaction, the director now directly owns 2,915 shares in the company, valued at approximately $790,781.20. The trade was a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,400 shares of company stock valued at $3,680,610. Company insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on CME shares. Piper Sandler raised their price objective on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Oppenheimer upped their price target on CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. JPMorgan Chase & Co. decreased their price objective on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Bank of America increased their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Finally, Barclays raised their target price on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Three analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $258.20.

CME Group Price Performance

Shares of CME Group stock traded down $1.46 during trading on Friday, hitting $269.50. The stock had a trading volume of 1,576,352 shares, compared to its average volume of 2,200,731. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The firm has a market cap of $97.12 billion, a P/E ratio of 27.87, a PEG ratio of 6.76 and a beta of 0.45. The business has a fifty day moving average of $272.73 and a two-hundred day moving average of $254.39. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. CME Group's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.50 earnings per share. On average, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's payout ratio is 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.